Varian bid for Sirtex clears regulatory hurdle

By staff writers

March 15, 2018 -- Varian Medical Systems' proposed acquisition of Sirtex Medical has been cleared by U.S. antitrust authorities and the German Federal Cartel Office (FCO).

The companies first announced their $1.3 billion deal in January 2018. The proposed acquisition is still subject to the approval of Sirtex shareholders, the Federal Court of Australia, and other customary closing conditions before final closure.

The U.S. antitrust authorities cited the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976 in permitting early termination of the waiting period for the deal. The German FCO has determined that the agreement does not violate the Act Against Restraints of Competition.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking